articleTop 1% cited

Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double‐blinded placebo‐controlled Moscow study

Clinical Endocrinology · 2010 · Vol. 73(5) · pp. 602–612

Svetlana Y. Kalinchenko✉Yuliya Tishova(Peoples' Friendship University of Russia)George MskhalayaLouis Gooren(Amsterdam UMC Location VUmc)Erik J. Giltay(Leiden University Medical Center)Farid Saad(Gulf Medical University)

View via DOI Publisher page

Abstract

Thirty weeks of T administration normalizing plasma T in hypogonadal men with the MetS improved some components of the MetS and a number of inflammatory markers.

Hormonal and reproductive studies Sexual function and dysfunction studies Pharmacology and Obesity TreatmentInternal medicineMedicineEndocrinologyMetabolic syndromePlaceboWaistBody mass indexLeptinInsulin resistanceLipid profile

MeSH terms

AdultAgedC-Reactive ProteinHumansHypogonadismInflammationInsulinLipidsMaleMiddle AgedTestosteroneTumor Necrosis Factor-alphaInterleukin-6Body Mass IndexInterleukin-10

Citations

330

FWCI

14.98

field-weighted impact

References

Percentile

99%

vs. same field & year

Citations per year

Cited by

Sex differences in immune responses